# IMMUNOLOGY QUALITY ASSESSMENT (IQA) PROGRAM

> **NIH NIH N01** · DUKE UNIVERSITY · 2022 · $1,735,601

## Abstract

Central to NIAID scientific priorities is the need to support the conduct of clinical studies for the prevention and treatment of HIV/AIDS and its infectious and non-infectious co-morbidities, domestically and internationally. The purpose of this contract is to provide a resource to evaluate and enhance the ability of U.S. and non-U.S. laboratories (Labs) to participate in NIAID-funded and collaborative clinical studies by: (1) monitoring the ability of Labs to reliably perform study-specified immunological tests and cryopreserve peripheral blood mononuclear cells (PBMCs) and other human biological samples; (2) facilitating the optimization, standardization and validation of immunological assay methodologies, with focus on laboratory-developed-tests (LDTs) for implementation in NIAID-supported studies; (3) helping Labs meet sponsor and regulatory requirements for good clinical laboratory practices (GCLP) and submission of data to regulatory agencies; and (4) hosting and maintaining an electronic data management system and document library in support of contract activities.
are also within the scope of the contract.

## Key facts

- **NIH application ID:** 10653768
- **Project number:** 75N93021C00010-P00004-9999-1
- **Recipient organization:** DUKE UNIVERSITY
- **Principal Investigator:** THOMAS DENNY
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $1,735,601
- **Award type:** —
- **Project period:** 2022-09-30 → 2023-09-29

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10653768

## Citation

> US National Institutes of Health, RePORTER application 10653768, IMMUNOLOGY QUALITY ASSESSMENT (IQA) PROGRAM (75N93021C00010-P00004-9999-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10653768. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*